IL87189A - History of pyridinium, their production process and their pharmaceutical compositions - Google Patents
History of pyridinium, their production process and their pharmaceutical compositionsInfo
- Publication number
- IL87189A IL87189A IL8718988A IL8718988A IL87189A IL 87189 A IL87189 A IL 87189A IL 8718988 A IL8718988 A IL 8718988A IL 8718988 A IL8718988 A IL 8718988A IL 87189 A IL87189 A IL 87189A
- Authority
- IL
- Israel
- Prior art keywords
- group
- compound
- formula
- mmol
- ethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/18—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19347987 | 1987-07-31 | ||
JP13890888 | 1988-06-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL87189A0 IL87189A0 (en) | 1988-12-30 |
IL87189A true IL87189A (en) | 1996-07-23 |
Family
ID=26471848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL8718988A IL87189A (en) | 1987-07-31 | 1988-07-22 | History of pyridinium, their production process and their pharmaceutical compositions |
Country Status (11)
Country | Link |
---|---|
US (1) | US4962113A (de) |
EP (1) | EP0301751B1 (de) |
JP (1) | JP2756975B2 (de) |
KR (1) | KR0125929B1 (de) |
AU (1) | AU613653B2 (de) |
CA (1) | CA1339645C (de) |
DE (1) | DE3879024T2 (de) |
DK (1) | DK421488A (de) |
HU (1) | HU211704A9 (de) |
IE (1) | IE69971B1 (de) |
IL (1) | IL87189A (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4981860A (en) * | 1989-01-30 | 1991-01-01 | Takeda Chemical Industries, Ltd. | Pyridinium nitrate, composition containing same and their use for inhibiting platelet activating factor |
FR2676053B1 (fr) * | 1991-05-03 | 1993-08-27 | Sanofi Elf | Nouveaux composes dialkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
US5208247A (en) * | 1991-08-01 | 1993-05-04 | American Cyanamid Company | Pyridinium compounds which are useful as antagonists of platelet activating factor |
US5314902A (en) * | 1993-01-27 | 1994-05-24 | Monsanto Company | Urea derivatives useful as platelet aggregation inhibitors |
ES2068742B1 (es) * | 1993-02-11 | 1995-11-16 | Uriach & Cia Sa J | Nuevos derivados de piridinio. |
ES2062943B1 (es) * | 1993-03-23 | 1995-11-16 | Uriach & Cia Sa J | Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas. |
DE69534213T2 (de) * | 1994-10-25 | 2006-01-12 | Astrazeneca Ab | Therapeutisch wirksame Heterocyclen |
US5998444A (en) * | 1995-10-24 | 1999-12-07 | Zeneca Ltd. | Piperidinyl compounds as NK1 or NK2 antagonists |
CA2206717A1 (en) * | 1996-06-03 | 1997-12-03 | Shiseido Company, Ltd. | Hair revitalizing tonic composition containing a lipid derivative and use thereof |
AU3463397A (en) * | 1996-07-25 | 1998-02-20 | Takeda Chemical Industries Ltd. | Crystalline pyridinium derivatives as paf-antagonists |
US6177067B1 (en) | 1996-08-09 | 2001-01-23 | Shiseido Company, Ltd. | Hair revitalizing tonic composition containing a 2,2-dimethylpropanediol compound and use thereof |
US8518546B2 (en) * | 2003-07-01 | 2013-08-27 | Transitions Optical, Inc. | Photochromic compounds and compositions |
US20110140056A1 (en) * | 2003-07-01 | 2011-06-16 | Transitions Optical, Inc. | Indeno-fused ring compounds |
US8545984B2 (en) * | 2003-07-01 | 2013-10-01 | Transitions Optical, Inc. | Photochromic compounds and compositions |
DE202009000591U1 (de) | 2009-01-19 | 2010-06-17 | Ets Energie Transfersysteme Ag | Aqua-Ofenbox |
TW201534586A (zh) | 2013-06-11 | 2015-09-16 | Orion Corp | 新穎cyp17抑制劑/抗雄激素劑 |
NZ762985A (en) | 2017-09-22 | 2024-03-22 | Jubilant Epipad LLC | Heterocyclic compounds as pad inhibitors |
HUE061607T2 (hu) | 2017-10-18 | 2023-07-28 | Jubilant Epipad LLC | Imidazopiridin vegyületek mint PAD inhibitorok |
CN111386265A (zh) | 2017-11-06 | 2020-07-07 | 朱比连特普罗德尔有限责任公司 | 作为pd1/pd-l1活化的抑制剂的嘧啶衍生物 |
EP3704120B1 (de) | 2017-11-24 | 2024-03-06 | Jubilant Episcribe LLC | Heterozyklische verbindungen als prmt5 inhibitoren |
BR112020018610A2 (pt) | 2018-03-13 | 2020-12-29 | Jubilant Prodel LLC | Compostos de fórmula i, fórmula ii, fórmula iii, fórmula iv, fórmula v, fórmula vi, ou seus polimorfos, estereoisômeros, tautômeros, profármacos, solvatos e sais farmaceuticamente aceitáveis dos mesmos e uso dos mesmos; processo de preparação; composição farmacêutica; e método para o tratamento e/ou prevenção de várias doenças, que incluem câncer e doenças infecciosas |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2270878B1 (de) * | 1974-05-15 | 1978-02-03 | Fabre Sa Pierre | |
US4657917A (en) | 1982-02-08 | 1987-04-14 | Research Corporation | Platelet aggregation inhibitory agents |
DK160818C (da) * | 1983-12-30 | 1991-10-07 | Hoffmann La Roche | N-ring-holdige glycerolderivater, fremgangsmaade til fremstilling deraf, anvendelse deraf til fremstilling af et blodpladeaktiveringsfaktorhaemmende middel samt laegemidler indeholdende en saadan forbindelse |
DE3586746D1 (de) * | 1984-04-03 | 1992-11-19 | Takeda Chemical Industries Ltd | Lipidderivate, ihre produktion und verwendung. |
WO1986000898A1 (en) * | 1984-07-19 | 1986-02-13 | University Of Florida | Compounds for site-enhanced delivery of radionuclides and uses thereof |
US4698093A (en) * | 1984-11-06 | 1987-10-06 | Monsanto Company | Herbicidal (2 or 6)-fluoroalkyl-4-amino pyridine derivatives |
DK161702C (da) * | 1985-04-04 | 1992-01-13 | Hoffmann La Roche | N-(2-phenoxyethyl)nicotinamid-derivater, deres fremstilling, fungicide midler indeholdende derivaterne, samt anvendelse af derivaterne og midlerne |
JP2556849B2 (ja) * | 1986-02-13 | 1996-11-27 | 三共株式会社 | グリセリン誘導体 |
-
1988
- 1988-07-20 DE DE88306622T patent/DE3879024T2/de not_active Expired - Fee Related
- 1988-07-20 EP EP88306622A patent/EP0301751B1/de not_active Expired - Lifetime
- 1988-07-22 IL IL8718988A patent/IL87189A/en not_active IP Right Cessation
- 1988-07-25 JP JP63186494A patent/JP2756975B2/ja not_active Expired - Fee Related
- 1988-07-26 US US07/224,352 patent/US4962113A/en not_active Expired - Fee Related
- 1988-07-27 AU AU20101/88A patent/AU613653B2/en not_active Ceased
- 1988-07-28 DK DK421488A patent/DK421488A/da not_active Application Discontinuation
- 1988-07-29 CA CA000573439A patent/CA1339645C/en not_active Expired - Fee Related
- 1988-07-29 IE IE233588A patent/IE69971B1/en not_active IP Right Cessation
- 1988-07-30 KR KR1019880009705A patent/KR0125929B1/ko not_active IP Right Cessation
-
1995
- 1995-06-30 HU HU95P/P00610P patent/HU211704A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
DE3879024D1 (de) | 1993-04-15 |
EP0301751A1 (de) | 1989-02-01 |
JPH0276854A (ja) | 1990-03-16 |
KR0125929B1 (ko) | 1997-12-26 |
DE3879024T2 (de) | 1993-10-07 |
US4962113A (en) | 1990-10-09 |
HU211704A9 (en) | 1995-12-28 |
AU613653B2 (en) | 1991-08-08 |
CA1339645C (en) | 1998-01-27 |
IE69971B1 (en) | 1996-10-16 |
DK421488A (da) | 1989-02-01 |
JP2756975B2 (ja) | 1998-05-25 |
IE882335L (en) | 1989-01-31 |
AU2010188A (en) | 1989-02-09 |
KR890002009A (ko) | 1989-04-07 |
DK421488D0 (da) | 1988-07-28 |
IL87189A0 (en) | 1988-12-30 |
EP0301751B1 (de) | 1993-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL87189A (en) | History of pyridinium, their production process and their pharmaceutical compositions | |
AU702832B2 (en) | Substituted aryl piperazines as neurokinin antagonists | |
DE69724811T2 (de) | Pentafluorobenzensulfonamide und analoge | |
AU736206B2 (en) | Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives | |
US7129252B2 (en) | Six membered amino-amide derivatives an angiogenisis inhibitors | |
DE60223373T2 (de) | Piperazinverbindungen | |
JPH09512272A (ja) | ニューロキニン−3拮抗物質としてのスピロ置換アザ環状化合物 | |
US7482468B2 (en) | Imidazole and benzimidazole derivatives useful as histamine H3 antagonists | |
KR20180095598A (ko) | 전압-게이팅 나트륨 채널에서 선택적 활성을 갖는 히드록시알킬아민- 및 히드록시시클로알킬아민-치환된 디아민-아릴술폰아미드 화합물 | |
KR20180096683A (ko) | 전압-게이팅 나트륨 채널에서 선택적 활성을 갖는 디아미노-알킬아미노-연결 아릴술폰아미드 화합물 | |
SK52394A3 (en) | Hiv protease inhibitors useful for the treatment of aids | |
JP2004520435A (ja) | 新規非イミダゾール化合物 | |
AU3675900A (en) | Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same | |
AU2083501A (en) | 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors | |
BG62083B1 (bg) | Hiv протеазни инхибитори във фармацевтични комбинации залечение на спин | |
JP2008520573A (ja) | 新規m3ムスカリン性アセチルコリン受容体アンタゴニスト | |
KR101911324B1 (ko) | 신규한 치환 이소퀴놀린 유도체 | |
US8394801B2 (en) | Quinoxaline derivatives and their use for treating benign and malignant tumour disorders | |
EP0739892B1 (de) | Chromon-Derivate | |
JP2004500415A (ja) | 化学療法を増進するための新規な化合物 | |
CZ20023952A3 (cs) | Derivát pyridin-2-ylaminoalkylkarbonylglycyl-beta-alaninu, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje | |
JPH0761992B2 (ja) | 置換アミン誘導体 | |
AU2010331949A1 (en) | Compounds for the treatment of neurologic disorders | |
US9359337B2 (en) | Acetamide derivatives | |
US6472397B1 (en) | Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |